Moreover, ADT+E4 more potently suppressed the endocrine parameters total and free T, prostate-specific antigen (PSA), and follicle-stimulating hormone (FSH), consistent with enhanced anti-tumor effects [7,8]. The gene discussed is KLK3; the disease is neoplasm.